首页> 外文期刊>Clinical pharmacokinetics >Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
【24h】

Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus

机译:胎儿母体生理基于药代动力学模型的胎盘转移整合,以表征胎儿暴露和胎儿代谢清除

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background and Objective Although acetaminophen is frequently used during pregnancy, little is known about fetal acetaminophen pharmacokinetics. Acetaminophen safety evaluation has typically focused on hepatotoxicity, while other events (fetal ductal closure/constriction) are also relevant. We aimed to develop a fetal-maternal physiologically based pharmacokinetic (PBPK) model (f-m PBPK) to quantitatively predict placental acetaminophen transfer, characterize fetal acetaminophen exposure, and quantify the contributions of specific clearance pathways in the term fetus. Methods An acetaminophen pregnancy PBPK model was extended with a compartment representing the fetal liver, which included maturation of relevant enzymes. Different approaches to describe placental transfer were evaluated (ex vivo cotyledon perfusion experiments, placental transfer prediction based on Caco-2 cell permeability or physicochemical properties [MoBi (R)]). Predicted maternal and fetal acetaminophen profiles were compared with in vivo observations. Results Tested approaches to predict placental transfer showed comparable performance, although the ex vivo approach showed highest prediction accuracy. Acetaminophen exposure in maternal venous blood was similar to fetal venous umbilical cord blood. Prediction of fetal acetaminophen clearance indicated that the median molar dose fraction converted to acetaminophen-sulphate and N-acetyl-p-benzoquinone imine was 0.8% and 0.06%, respectively. The predicted mean acetaminophen concentration in the arterial umbilical cord blood was 3.6 mg/L. Conclusion The median dose fraction of acetaminophen converted to its metabolites in the term fetus was predicted. The various placental transfer approaches supported the development of a generic f-m PBPK model incorporating in vivo placental drug transfer. The predicted arterial umbilical cord acetaminophen concentration was far below the suggested postnatal threshold (24.47 mg/L) for ductal closure.
机译:背景和目标虽然乙酰氨基酚经常在妊娠期间使用,但对于胎儿乙酰氨基酚的药代动力学众所周知。对乙酰氨基酚的安全评估通常集中在肝毒性上,而其他事件(胎儿导管闭合/收缩)也是相关的。我们旨在开发胎儿生理基础的药代动力学(PBPK)模型(F-M PBPK),以定量地预测胎盘乙酰氨基酚转移,表征胎儿乙酰氨基酚暴露,并量化术语胎儿术语中特定清除途径的贡献。方法使用代表胎儿肝脏的隔室延伸,乙酰氨基酚妊娠PBPK模型延伸,其包括相关酶的成熟。评估描述胎盘转移的不同方法(exVivo子叶灌注实验,基于Caco-2细胞渗透性或物理化学性质的胎盘传递预测[Mobi(R)])。将预测母体和胎儿乙酰氨基酚型与体内观察结果进行了比较。结果预测胎盘转移的测试方法表现出相当的性能,尽管前体内方法显示出最高的预测精度。母体静脉血中的乙酰氨基酚暴露类似于胎儿静脉脐带血。胎儿乙酰氨基酚的预测表明,转化为乙酰氨基酚 - 硫酸酯和N-乙酰基-P-苯醌亚胺的中值剂量级分别为0.8%和0.06%。动脉脐带血中预测的平均乙酰氨基酚浓度为3.6mg / L.结论预测了乙酰氨基酚乙酰乙酰酮在胎儿中转化为其代谢物的中值级分数。各种胎盘转移方法支持开发包含体内胎盘药物转移的通用F-M PBPK模型。预测的动脉脐带乙酰氨基酚浓度远远低于导管闭合的建议的后阈值(24.47mg / L)。

著录项

  • 来源
    《Clinical pharmacokinetics》 |2020年第7期|共15页
  • 作者单位

    Erasmus MC Sophia Childrens Hosp Intens Care Rotterdam Netherlands;

    Katholieke Univ Leuven Dept Dev &

    Regenerat Leuven Belgium;

    Katholieke Univ Leuven Dept Dev &

    Regenerat Leuven Belgium;

    Katholieke Univ Leuven Drug Delivery &

    Disposit Lab Dept Pharmaceut &

    Pharmacol Sci Leuven;

    Erasmus MC Sophia Childrens Hosp Intens Care Rotterdam Netherlands;

    Pediat Pharmacol Pharmacometr Res Ctr Basel Switzerland;

    Katholieke Univ Leuven Dept Dev &

    Regenerat Leuven Belgium;

    Erasmus MC Sophia Childrens Hosp Intens Care Rotterdam Netherlands;

    Pediat Pharmacol Pharmacometr Res Ctr Basel Switzerland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号